| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | 2017 | High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response | Arrizabalaga, Olatz; Moreno-Cugnon, Leire; Auzmendi-Iriarte, Jaione; Aldaz, Paula; Ibáñez de Cáceres, Inmaculada CSIC ORCID; Garros-Regulez, Laura; Moncho-Amor, Verónica CSIC; Torres-Bayona, Sergio; Pernía, Olga CSIC; Pintado-Berninches, Laura CSIC ORCID ; Carrasco-Ramírez, Patricia CSIC; Cortés-Sempere, María CSIC; Rosas, Rocio; Sánchez-Gómez, Pilar CSIC; Ruiz, Irune; Caren, Helena; Pollard, Steven; García, Idoia; Ayuso-Sacido, Angel; Lovell-Badge, Robin; Belda-Iniesta, Cristobal; Sampron, Nicolas; Perona Abellón, Rosario CSIC ORCID; Matheu, Ander | artículo |
| closedAccess |  | 2013 | IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer | Cortés-Sempere, María CSIC; Castro Carpeño, Javier de; Nistal, Manuel; Belda-Iniesta, Cristobal; Perona Abellón, Rosario CSIC ORCID; Ibáñez de Cáceres, Inmaculada CSIC ORCID | artículo |
| openAccess |  | 19-dic-2018 | Method for predicting the response to treatment with radiotherapy combined with chemotherapy based on cisplatin | Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC | solicitud de patente |
| openAccess |  | 4-dic-2014 | Method for predicting the response to treatment with radiotherapy combined with chemotherapy based on cisplatin | Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC | solicitud de patente |
| openAccess |  | 13-abr-2016 | Method for predicting the response to treatment with radiotherapy combined with chemotherapy based on cisplatin | Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC | solicitud de patente |
| openAccess |  | 5-may-2016 | Method for predicting the response to treatment with radiotherapy combined with chemotherapy based on cisplatin | Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC | solicitud de patente |
| closedAccess |  | 6-dic-2014 | Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy | Pernía, Olga CSIC; Cortés-Sempere, María CSIC; Macías, María-Teresa CSIC; Ibáñez de Cáceres, Inmaculada CSIC ORCID | artículo |
| openAccess |  | 12-jun-2019 | Método para predecir la respuesta al tratamiento con radioterapia combinada con quimioterapia basada en cisplatino | Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC | traducción de patente |
| openAccess |  | 28-ene-2015 | Método para predecir la respuesta al tratamiento con radioterapia combinada con quimioterapia basada en cisplatino | Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC | solicitud de patente |
| openAccess |  | 28-ene-2015 | Método para predecir la respuesta al tratamiento con radioterapia combinada con quimioterapia basada en cisplatino | Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC | patente |
| closedAccess |  | 2011 | microRNAs as novel epigenetic biomarkers for human cancer | Cortés-Sempere, María CSIC; Ibáñez de Cáceres, Inmaculada CSIC ORCID | artículo |
| closedAccess |  | 2009 | Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin | Cortés-Sempere, María CSIC; Rodriguez-Fanjul, V. CSIC ORCID; Sánchez-Pérez, Isabel CSIC ORCID; Perona Abellón, Rosario CSIC ORCID; Albanell, Joan | artículo |
| closedAccess |  | 2009 | MKP1 repression is required for the chemosensitizing effects of NF-κB and PI3K inhibitors to cisplatin in non-small cell lung cancer | Cortés-Sempere, María CSIC; Rodriguez-Fanjul, V. CSIC ORCID; Belda-Iniesta, Cristobal; Cejas, Paloma; Machado-Pinilla, R. CSIC; Manguan-García, Cristina CSIC ORCID; Sánchez-Pérez, Isabel CSIC ORCID; Nistal, Manuel; Moratilla, Carmen CSIC; Castro Carpeño, Javier de; González Barón, Manuel; Albanell, Joan; Perona Abellón, Rosario CSIC ORCID | artículo |
| openAccess |  | 9-oct-2018 | Probe for detecting and/or quantifying methylation of the promoter of the IGFBP-3 gene | Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC | solicitud de patente |
| openAccess |  | 2019 | Role of Dusp6 phosphatase as a tumor suppressor in non-small cell lung cancer | Moncho-Amor, Verónica CSIC; Pintado-Berninches, Laura CSIC ORCID ; Ibáñez de Cáceres, Inmaculada CSIC ORCID; Martín-Villar, Ester CSIC ORCID; Quintanilla, Miguel CSIC ORCID; Chakravarty, Probir; Cortés-Sempere, María CSIC; Fernández-Varas, Beatriz CSIC; Rodriguez-Antolín, Carlos; Castro Carpeño, Javier de; Sastre, Leandro CSIC ORCID; Perona Abellón, Rosario CSIC ORCID | artículo |
| closedAccess |  | 2008 | The role of the NFκB signalling pathway in cancer | Cortés-Sempere, María CSIC; Rodriguez-Fanjul, V. CSIC ORCID; Sánchez-Pérez, Isabel CSIC ORCID; Perona Abellón, Rosario CSIC ORCID | artículo |
